Pasithea Therapeutics Corp - Warrants (11/08/2026

(Warrants)
NAS:KTTAW (USA)   Warrants (11/08/2026)
$ 0.01 0 (0%) 02:22 PM EST
At Loss
P/B:
0.30
Volume:
-
Avg Vol (2M):
-
Volume:
-
At Loss
Avg Vol (2M):
-

Business Description

Pasithea Therapeutics Corp
NAICS : 541714 SIC : 2834

Share Class Description:

KTTAW: Warrants (11/08/2026)
Description
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
Name Current Vs Industry Vs History
Cash-To-Debt 363.91
Equity-to-Asset 0.89
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.35
Quick Ratio 5.35
Cash Ratio 4.87

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 6.8
Name Current Vs Industry Vs History
ROE % -55.63
ROA % -51.09
ROIC % -165.31
ROC (Joel Greenblatt) % -3925.27
ROCE % -56.83

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.3
EV-to-EBIT 0.36
EV-to-EBITDA 0.37
EV-to-FCF 0.44
Earnings Yield (Greenblatt) % 277.78
FCF Yield % -231.28

Financials (Next Earnings Date:2024-08-09 Est.)

KTTAW's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KTTAW

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Pasithea Therapeutics Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 1.59
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pasithea Therapeutics Corp Filings

Filing Date Document Date Form
No Filing Data

Pasithea Therapeutics Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Pasithea Therapeutics Corp Frequently Asked Questions

What is Pasithea Therapeutics Corp(KTTAW)'s stock price today?
The current price of KTTAW is $0.01. The 52 week high of KTTAW is $1.59 and 52 week low is $0.00.
When is next earnings date of Pasithea Therapeutics Corp(KTTAW)?
The next earnings date of Pasithea Therapeutics Corp(KTTAW) is 2024-08-09 Est..
Does Pasithea Therapeutics Corp(KTTAW) pay dividends? If so, how much?
Pasithea Therapeutics Corp(KTTAW) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1